Pharma channel feed – Endpoints News

Pharma channel feed

Teva fined €462.6M by European regulators over Copaxone patent and competition allegations

7 months ago

Federal court backs FDA's approval of competitor to Jazz's sleep drug

7 months ago

‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar

7 months ago

Gardasil demand in China sinks, and Merck expects the same next quarter

7 months ago

Takeda says multiyear restructuring is 'on track'

7 months ago

Argenx reports Vyvgart sales streak, bolstered by launch in rare neuro disorder

7 months ago

AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M

7 months ago

Bristol Myers ups revenue guidance again, raising confidence in cost-cutting

7 months ago

AbbVie’s immunology blockbusters make up for Humira sales drop in Q3

7 months ago

Hints of impatience grow with Biogen as it tries to find a bridge to growth

7 months ago

Biogen signs molecular glue deal, raises yearly projections

7 months ago

Updated: Lilly’s shares tank after trimming revenue guidance. It also cut three assets

7 months ago

GSK remains ‘very confident’ in RSV vaccine amid competition, sales slump

7 months ago

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

7 months ago

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

7 months ago

Lexicon's once-rejected diabetes drug is questioned again by FDA ahead of adcomm

7 months ago

Novartis expands Scemblix label to first-line CML patients

7 months ago

Shionogi touts topline data for Covid-19 antiviral for post-exposure treatment

7 months ago

Novartis highlights overall M&A track record following MorphoSys impairment

7 months ago

In bid to lower ARIA-E, Eli Lilly tries a different dosing regimen for its Alzheimer's drug

7 months ago

#HLTH24: GLP-1 compounding pharmacies took center stage at digital health’s biggest conference

7 months ago

Updated: Pfizer’s Covid pill powers guidance raise, but shortfall elsewhere raises questions

7 months ago

Corrected: Genmab lines up T cell engager pact with Revitope

7 months ago

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

7 months ago

First page Previous page 28 29 303132 33 34 Next page Last page